Kornitzer Capital Management Inc. KS raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 175,635 shares of the medical research company’s stock after buying an additional 4,565 shares during the quarter. Kornitzer Capital Management Inc. KS owned about 0.05% of Agilent Technologies worth $11,276,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in A. JPMorgan Chase & Co. raised its stake in Agilent Technologies by 45.2% during the second quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock valued at $720,358,000 after buying an additional 3,779,099 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in Agilent Technologies by 720.6% during the second quarter. PNC Financial Services Group Inc. now owns 1,131,276 shares of the medical research company’s stock valued at $67,097,000 after buying an additional 993,414 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of Agilent Technologies during the 2nd quarter worth approximately $58,693,000. Voya Investment Management LLC raised its position in shares of Agilent Technologies by 444.0% during the 2nd quarter. Voya Investment Management LLC now owns 1,032,128 shares of the medical research company’s stock worth $61,215,000 after purchasing an additional 842,398 shares during the period. Finally, Janus Henderson Group PLC raised its position in shares of Agilent Technologies by 2,135.0% during the 2nd quarter. Janus Henderson Group PLC now owns 836,051 shares of the medical research company’s stock worth $49,587,000 after purchasing an additional 798,643 shares during the period.

ILLEGAL ACTIVITY NOTICE: “Kornitzer Capital Management Inc. KS Increases Holdings in Agilent Technologies, Inc. (A)” was originally published by Daily Political and is owned by of Daily Political. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.dailypolitical.com/2017/11/07/kornitzer-capital-management-inc-ks-increases-holdings-in-agilent-technologies-inc-a.html.

In other news, CFO Didier Hirsch sold 15,555 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the completion of the sale, the chief financial officer now directly owns 178,557 shares of the company’s stock, valued at approximately $11,784,762. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Dominique Grau sold 13,007 shares of the firm’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $62.00, for a total value of $806,434.00. Following the sale, the insider now directly owns 60,098 shares of the company’s stock, valued at $3,726,076. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 165,720 shares of company stock valued at $10,488,739.

Agilent Technologies, Inc. (NYSE A) opened at $68.22 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.76 and a current ratio of 3.22. The stock has a market capitalization of $22,003.38, a price-to-earnings ratio of 29.86, a price-to-earnings-growth ratio of 2.68 and a beta of 1.27. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $68.67.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the company posted $0.49 EPS. equities research analysts predict that Agilent Technologies, Inc. will post 2.32 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd were paid a dividend of $0.132 per share. This represents a $0.53 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend was Monday, October 2nd. Agilent Technologies’s payout ratio is currently 27.32%.

A number of analysts have recently weighed in on the company. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a research report on Tuesday, October 31st. Robert W. Baird reiterated a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Friday, October 20th. Cowen and Company reiterated a “hold” rating and set a $65.00 price target on shares of Agilent Technologies in a research report on Thursday, September 28th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $68.00 price target on shares of Agilent Technologies in a research report on Tuesday, September 26th. Finally, Bank of America Corporation increased their price target on Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 16th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $65.78.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.